Insider Title Company Date Price Return Shares Value
Engleman Edgar Non-Executive Director Bolt Biotherapeutics, Inc. (BOLT) 2021-02-09 $400.00 -99.8% 10,000 $4,000,000
Return Profit / (loss) Cost
Total -99.8% $-3,993,500 $4,000,000